Disease | breast cancer |
Phenotype | C0015230|rash |
Sentences | 2 |
PubMedID- 25216762 | Development of prediction tools for diarrhea and rash in breast cancer patients receiving lapatinib in combination with capecitabine. |
PubMedID- 25344257 | Development of prediction tools for diarrhea and rash in breast cancer patients receiving lapatinib in combination with capecitabine: rule of thumb in prediction studies. |
Page: 1